Florbetapir (18f)    (DrugBank: -)

1 disease
IDDisease name (Link within this page)Number of trials
127Frontotemporal lobar degeneration1

127. Frontotemporal lobar degeneration    [ 74 clinical trials,   83 drugs,   (DrugBank: 28 drugs),   29 drug target genes,   99 drug target pathways]
Searched query = "Frontotemporal lobar degeneration", "Frontotemporal dementia", "Semantic dementia"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 74 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2014-001315-40-IT
(EUCTR)
03/12/201410/10/2014Florbetapir-PET scan in subjects with a known mutation for autosomal dominant Alzheimer's Disease taking part in the ItalianDIAfN studyAmyloid Imaging in the Italian Network for autosomal dominant Alzheimer’s disease and frontotemporal lobar degeneration (ItalianDIAfN)” - Amyloid-PET in ItalianDIAfN Autosomal Dominant Alzheimer's Disease
MedDRA version: 17.0;Level: LLT;Classification code 10001896;Term: Alzheimer's disease;System Organ Class: 100000004852;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
Trade Name: Amyvid
Product Name: Florbetapir (18F)
Product Code: Florbetapir (18F)
INN or Proposed INN: florbetapir (18F)
Other descriptive name: N/A
IRCCS Istituto Centro San Giovanni di Dio FatebenefratelliNULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes
Italy